PapersPMID:27320846
The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial.
What moved
1 findingHow to read these marks →“However, the addition of GTP to the existing treatment regimen significantly reduced mean serum DKK-1 (p = 0.004) and tumor necrosis factor alpha (TNF-α; p = 0.003) with no significant change in urinary 8-isoprostane concentrations (Table 3).”
- Study
- RCT
- Duration
- 3 months
- Dose studied
- four capsules daily of green tea polyphenols (TP98) corresponding to 800 mg EGCG
- Population
- Adults with type 1 or type 2 diabetes and persistent albuminuria (UACR over 30 mg/g) despite maximum-dose ACE inhibitor or ARB treatment, which both arms continued; 21 completed in each arm
Study record
- Design
- randomised controlled trial
- Species
- human / mixed
- Population
- 42 adults with type 1 or type 2 diabetes and persistent albuminuria (UACR over 30 mg/g) despite maximum doses of ACE inhibitors and/or ARBs; green tea polyphenols (800 mg EGCG/day) vs placebo; plus in vitro immortalized human podocyte experiments with patient plasma and EGCG
- Participants
- 42
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 20
- Declined
- the intervention held more than the compound